FCGR2B and atherosclerosis: Murine models support a role for activating FcγRs in the development of atherosclerosis [102–105] and suggest that the inhibitory receptor FcγRIIB regulates their pathogenic effects; both apo-E and LDLR-deficient mice develop a more severe disease in the absence of FcγRIIB [106, 107].